European stocks are likely to start positive as AstraZeneca's COVID-19 vaccine has been approved for emergency supply in the UK, despite mixed Asian performance and the negative cues from Wall Street amid uncertainty about whether the U.S. Senate would approve planned increase in stimulus checks.
from RTT - Top Story https://ift.tt/3rOG3yq
via IFTTT
from RTT - Top Story https://ift.tt/3rOG3yq
via IFTTT
Comments
Post a Comment